1 paper
Xiangyu Li, Xinjie Liang, Gongning Luo +3
Neoadjuvant therapy (NAT) for breast cancer is a common treatment option in clinical practice. Tumor cellularity (TC), which represents the percentage of invasive tumors in the tum…